Target Name: ZNF691
NCBI ID: G51058
Other Name(s): Zinc finger protein 691, transcript variant 1 | Zinc finger protein 691 (isoform 1) | zinc finger protein 691 | RP11-342M1.5 | Zinc finger protein 691 | ZN691_HUMAN | ZNF691 variant 1 | Zfp691

ZNF691: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transcription factors, which play a crucial role in gene regulation and have been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. ZNF691, also known as Zinc finger protein 691, is a specific ZFP that has gained significant attention due to its potential involvement in diseases and its potential as a drug target or biomarker.

Gene Expression and Function

ZNF691 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and peripheral tissues. It is highly conserved, with a calculated pI of 12.9 and a predicted localization in the cytoplasm. ZNF691 functions as a transcription factor to regulate gene expression by binding to specific DNA sequences. It has been shown to play a role in various cellular processes, including cell growth, apoptosis, and inflammation.

In addition to its function as a transcription factor, ZNF691 has also been shown to play a role in protein-protein interactions and as a scaffold for various cellular structures. It has been shown to interact with other transcription factors, such as NF-kappa-B and p53, and has been shown to be involved in the regulation of cellular processes, including cell adhesion, migration, and the regulation of cell cycle progression.

Disease association and potential drug targets

The involvement of ZNF691 in various diseases has led to its potential as a drug target or biomarker. ZNF691 has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In cancer, ZNF691 has been shown to play a role in the regulation of cell cycle progression and the maintenance of stem-like characteristics. It has been shown to promote the growth and survival of cancer cells and has been shown to be involved in the development of resistance to chemotherapy in cancer cells.

In neurodegenerative diseases, ZNF691 has been shown to play a role in the regulation of neurotransmitter synthesis and function. It has been shown to be involved in the regulation of dopamine synthesis and have been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In developmental disorders, ZNF691 has been shown to play a role in the regulation of cell proliferation and the development of various organs. It has been shown to be involved in the development of neural tube and has been shown to play a role in the regulation of neurodevelopmental disorders, including Down syndrome and Fragile X syndrome.

Potential biomarkers

The potential use of ZNF691 as a biomarker for various diseases makes it an attractive target for drug development. By inhibiting the activity of ZNF691, researchers can study its effects on cellular processes and identify potential drug targets.

One approach to identifying potential biomarkers for ZNF691 is to use small interfering RNA (siRNA) technology. siRNA is a technique that allows researchers to specifically target and suppress the expression of specific genes. By using siRNA to knock down the expression of ZNF691, researchers can study its effects on cellular processes and identify potential drug targets.

Another approach to identifying potential biomarkers for ZNF691 is to use mass spectrometry (MS) to identify changes in the expression of ZNF691 in response to specific treatments or conditions. MS is a technique that allows researchers to identify and quantify specific proteins in a sample. By using MS to identify changes in the expression of ZNF691, researchers can study its effects on cellular processes and identify potential drug targets.

Conclusion

ZNF691 is a potential drug target and biomarker that has significant implications for the development of new therapies for various diseases. Its involvement in various diseases, including cancer, neurodegenerative diseases, and developmental disorders, makes it an attractive target for drug development. The potential use of ZNF691 as a biomarker and drug target is further supported by its role as a transcription factor and its involvement in protein-protein interactions. Further research is needed to fully understand the potential of ZNF691 as a drug target and biomarker.

Protein Name: Zinc Finger Protein 691

Functions: May be involved in transcriptional regulation

More Common Targets

ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813